CCN1, CCN2, CCN3, and CCN4 are pro-tumorigenic and may be responsible for human breast carcinoma; while CCN1, CCN3, CCN5 and CCN6 have anti-tumorigenic effects (see Figure 1). This evidence concerns the gene CCN4 and breast carcinoma.